The question of whether chemotherapy is necessary for rectal cancer needs to be analyzed specifically, taking into account factors such as the patient's physical condition, pathological staging, and whether the surgery was completely successful. Chemotherapy for colorectal cancer can be divided into adjuvant chemotherapy and palliative chemotherapy for advanced colorectal cancer, and it can also serve to enhance the effects of radiotherapy. For low rectal cancer, neoadjuvant chemoradiotherapy can be administered if the tumor cannot be directly removed, followed by surgery after the treatment. If surgery is possible for rectal cancer, and there is lymph node metastasis or the pathological stage is relatively advanced, postoperative adjuvant chemotherapy can be performed. Therefore, the need for chemotherapy in cases of rectal cancer should ideally be assessed at a specialized oncology department in a hospital to provide a detailed analysis and evaluation by oncologists.